Integrated BioTherapeutics
company
About
AIntegrated BioTherapeutics is a focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases.
- 11 - 50
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $6.60M
- Industries
- Biotechnology,Health Care,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 11 - 50
- Operating Status
- Active
A biotechnology company focused on the discovery of novel vaccines and therapeutics for emerging infectious diseases. It antiviral pipeline includes unique pan-filovirus antibody candidates, vaccines and a variety of other product candidates for emerging viruses.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$6.60M
Integrated BioTherapeutics has raised a total of
$6.60M
in funding over 2 rounds. Their latest funding was raised on
Aug 2, 2017 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 2, 2017 | Grant | $6.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Integrated BioTherapeutics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Institutes of Health
|
— | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
